PT Murni Sadar Tbk (MTMH.JK)
IDR 980.0
(-2.49%)
IDR 980.0
(-2.49%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 167.6 Billion IDR | -23.09% |
| 2022 | 217.91 Billion IDR | -48.78% |
| 2021 | 425.46 Billion IDR | 153.38% |
| 2020 | 167.91 Billion IDR | 90.64% |
| 2019 | 88.07 Billion IDR | 13.59% |
| 2018 | 77.53 Billion IDR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 74.89 Billion IDR | 35.4% |
| 2024 Q2 | 55.31 Billion IDR | -6.12% |
| 2024 Q1 | 58.91 Billion IDR | 48.96% |
| 2023 Q2 | 38.25 Billion IDR | -35.66% |
| 2023 Q3 | 69.53 Billion IDR | 81.75% |
| 2023 Q4 | 39.54 Billion IDR | -43.12% |
| 2023 Q1 | 59.46 Billion IDR | 25.05% |
| 2023 FY | 167.6 Billion IDR | -23.09% |
| 2022 FY | 217.91 Billion IDR | -48.78% |
| 2022 Q4 | 47.55 Billion IDR | 8.07% |
| 2022 Q2 | 38.49 Billion IDR | -56.19% |
| 2022 Q1 | 87.86 Billion IDR | 35.3% |
| 2022 Q3 | 44 Billion IDR | 14.32% |
| 2021 Q1 | 133.23 Billion IDR | 0.0% |
| 2021 Q3 | 90.63 Billion IDR | -31.97% |
| 2021 Q2 | 133.23 Billion IDR | 0.0% |
| 2021 FY | 425.46 Billion IDR | 153.38% |
| 2021 Q4 | 64.93 Billion IDR | -28.35% |
| 2020 FY | 167.91 Billion IDR | 90.64% |
| 2019 FY | 88.07 Billion IDR | 13.59% |
| 2018 FY | 77.53 Billion IDR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| PT Bundamedik Tbk | 582.25 Billion IDR | 71.215% |
| PT Metro Healthcare Indonesia Tbk | 89.65 Billion IDR | -86.946% |
| PT Medikaloka Hermina Tbk | 1824.23 Billion IDR | 90.812% |
| PT Mitra Keluarga Karyasehat Tbk | 1968.05 Billion IDR | 91.484% |
| PT Famon Awal Bros Sedaya Tbk | 515.99 Billion IDR | 67.518% |
| PT Royal Prima Tbk | 75.23 Billion IDR | -122.771% |
| PT Kedoya Adyaraya Tbk | 128.11 Billion IDR | -30.826% |
| PT Sarana Meditama Metropolitan Tbk | 434.04 Billion IDR | 61.385% |
| PT Siloam International Hospitals Tbk | 3644.9 Billion IDR | 95.402% |
| PT Sejahteraraya Anugrahjaya Tbk | 718.02 Billion IDR | 76.657% |